| Year |
Citation |
Score |
| 2020 |
Rahimi L, Malek M, Ismail-Beigi F, Khamseh ME. Challenging Issues in the Management of Cardiovascular Risk Factors in Diabetes During the COVID-19 Pandemic: A Review of Current Literature. Advances in Therapy. 37: 3450-3462. PMID 32632851 DOI: 10.1007/S12325-020-01417-8 |
0.353 |
|
| 2020 |
Rajpal A, Ismail-Beigi F. Intermittent Fasting and "Metabolic Switch": Effects on Metabolic Syndrome, Pre-diabetes and Type 2 Diabetes Mellitus. Diabetes, Obesity & Metabolism. PMID 32372521 DOI: 10.1111/Dom.14080 |
0.306 |
|
| 2020 |
Rahimi L, Rajpal A, Ismail-Beigi F. Glucocorticoid-Induced Fatty Liver Disease. Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy. 13: 1133-1145. PMID 32368109 DOI: 10.2147/Dmso.S247379 |
0.345 |
|
| 2020 |
Yang JF, Gong X, Bakh NA, Carr K, Phillips NFB, Ismail-Beigi F, Weiss MA, Strano MS. Connecting Rodent and Human Pharmacokinetic Models for the Design and Translation of Glucose-Responsive Insulin. Diabetes. PMID 32152206 DOI: 10.2337/Db19-0879 |
0.306 |
|
| 2020 |
Hashemi Madani N, Ismail-Beigi F, Poustchi H, Nalini M, Sepanlou SG, Malek M, Abbasi MA, Khajavi A, Khamseh ME, Malekzadeh R. Impaired fasting glucose and major adverse cardiovascular events by hypertension and dyslipidemia status: the Golestan cohort study. Bmc Cardiovascular Disorders. 20: 113. PMID 32138676 DOI: 10.1186/S12872-020-01390-8 |
0.367 |
|
| 2020 |
Rege NK, Liu M, Dhayalan B, Chen YS, Smith NA, Rahimi L, Sun J, Guo H, Yang Y, Haataja L, Phillips NFB, Whittaker J, Smith BJ, Arvan P, Ismail-Beigi F, et al. "Register-shift" insulin analogs uncover constraints of proteotoxicity in protein evolution. The Journal of Biological Chemistry. PMID 32005662 DOI: 10.1074/Jbc.Ra119.011389 |
0.342 |
|
| 2019 |
Razavi-Nematollahi L, Ismail-Beigi F. Adverse Effects of Glycemia-Lowering Medications in Type 2 Diabetes. Current Diabetes Reports. 19: 132. PMID 31748838 DOI: 10.1007/S11892-019-1266-7 |
0.368 |
|
| 2019 |
Molla GJ, Ismail-Beigi F, Larijani B, Khaloo P, Moosaie F, Alemi H, Mansournia MA, Ghadimi T, Ghaemi F, Nakhjavani M, Esteghamati A. Smoking and Diabetes Control in Adults With Type 1 and Type 2 Diabetes: A Nationwide Study From the 2018 National Program for Prevention and Control of Diabetes of Iran. Canadian Journal of Diabetes. PMID 31494031 DOI: 10.1016/J.Jcjd.2019.07.002 |
0.318 |
|
| 2019 |
Esteghamati A, Ismail-Beigi F, Khaloo P, Moosaie F, Alemi H, Mansournia MA, Afarideh M, Janbabaei Molla G, Ghadimi T, Shadnoush M, Kermanchi J, Ghaemi F. Determinants of glycemic control: Phase 2 analysis from nationwide diabetes report of National Program for Prevention and Control of Diabetes (NPPCD-2018). Primary Care Diabetes. PMID 31402326 DOI: 10.1016/J.Pcd.2019.07.002 |
0.343 |
|
| 2019 |
Gharaibeh NE, Rahhal MN, Rahimi L, Ismail-Beigi F. SGLT-2 inhibitors as promising therapeutics for non-alcoholic fatty liver disease: pathophysiology, clinical outcomes, and future directions. Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy. 12: 1001-1012. PMID 31308716 DOI: 10.2147/Dmso.S212715 |
0.311 |
|
| 2019 |
Rahhal MN, Gharaibeh NE, Rahimi L, Ismail-Beigi F. Disturbances in Insulin-Glucose Metabolism in Patients with Advanced Renal Disease with and without Diabetes. The Journal of Clinical Endocrinology and Metabolism. PMID 31162534 DOI: 10.1210/Jc.2019-00286 |
0.378 |
|
| 2019 |
Chehregosha H, Khamseh ME, Malek M, Hosseinpanah F, Ismail-Beigi F. A View Beyond HbA1c: Role of Continuous Glucose Monitoring. Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders. PMID 31037553 DOI: 10.1007/S13300-019-0619-1 |
0.416 |
|
| 2019 |
Rachdaoui N, Polo-Parada L, Ismail-Beigi F. Prolonged Exposure to Insulin Inactivates Akt and Erk and Increases Pancreatic Islet and INS1E -Cell Apoptosis. Journal of the Endocrine Society. 3: 69-90. PMID 30697602 DOI: 10.1210/Js.2018-00140 |
0.336 |
|
| 2018 |
Taheri N, Aminorroaya A, Ismail-Beigi F, Amini M. DEXAMETHASONE STRESS TEST: A PILOT CLINICAL STUDY FOR IDENTIFICATION OF INDIVIDUALS HIGHLY PRONE TO DEVELOP TYPE 2 DIABETES. Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. PMID 30084689 DOI: 10.4158/Ep-2018-0188 |
0.355 |
|
| 2018 |
Rege NK, Wickramasinghe NP, Tustan AN, Phillips NFB, Yee VC, Ismail-Beigi F, Weiss MA. Structure-Based Stabilization of Insulin as a Therapeutic Protein Assembly via Enhanced Aromatic-Aromatic Interactions. The Journal of Biological Chemistry. PMID 29880646 DOI: 10.1074/Jbc.Ra118.003650 |
0.307 |
|
| 2018 |
Rasouli N, Cohen RM, Defronzo RA, Inzucchi S, Ismail-Beigi F, Kahn SE, Utzschneider K, Lachin J, Younes N. Relationship between Baseline Phenotype and Measures of Insulin Sensitivity and Beta-Cell Responses in the GRADE Cohort Diabetes. 67. DOI: 10.2337/Db18-1822-P |
0.309 |
|
| 2018 |
Utzschneider K, Banerji MA, Barzilay JI, Gonzalez EV, Ismail-Beigi F, Mather KJ, Raskin P, Younes N, Kahn SE. Does the Shape of the OGTT Glucose Curve Reflect Metabolic Function in Individuals with Type 2 Diabetes? Baseline Data from the GRADE Cohort Diabetes. 67. DOI: 10.2337/Db18-1811-P |
0.375 |
|
| 2018 |
Utzschneider K, Banerji MA, Barzilay JI, Gonzalez EV, Ismail-Beigi F, Mather KJ, Raskin P, Younes N, Kahn SE. Metabolic Function in 5,047 Adults with Type 2 Diabetes on Metformin Alone Based on Oral Glucose Tolerance Test (OGTT) Data from the GRADE Cohort Diabetes. 67. DOI: 10.2337/Db18-1661-P |
0.316 |
|
| 2017 |
Glidden MD, Aldabbagh K, Phillips NB, Carr K, Chen YS, Whittaker J, Phillips M, Wickramasinghe NP, Rege N, Swain M, Peng Y, Yang Y, Lawrence MC, Yee VC, Ismail-Beigi F, et al. An ultra-stable single-chain insulin analog resists thermal inactivation and exhibits biological signaling duration equivalent to the native protein. The Journal of Biological Chemistry. PMID 29114035 DOI: 10.1074/Jbc.M117.808626 |
0.332 |
|
| 2017 |
Esteghamati A, Larijani B, Aghajani MH, Ghaemi F, Kermanchi J, Shahrami A, Saadat M, Esfahani EN, Ganji M, Noshad S, Khajeh E, Ghajar A, Heidari B, Afarideh M, Mechanick JI, ... Ismail-Beigi F, et al. Diabetes in Iran: Prospective Analysis from First Nationwide Diabetes Report of National Program for Prevention and Control of Diabetes (NPPCD-2016). Scientific Reports. 7: 13461. PMID 29044139 DOI: 10.1038/S41598-017-13379-Z |
0.387 |
|
| 2017 |
Cukierman-Yaffe T, Gerstein HC, Miller ME, Launer LJ, Williamson J, Horowitz KR, Ismail-Beigi F, Lazar RM. The relationship between the score on a simple measure of cognitive function & incident CVD in people with diabetes: a post-hoc epidemiological analysis from the ACCORD-MIND study. The Journal of Clinical Endocrinology and Metabolism. PMID 28575229 DOI: 10.1210/Jc.2016-3480 |
0.317 |
|
| 2017 |
Ismail-Beigi F, Moghissi E, Kosiborod M, Inzucchi SE. Shifting Paradigms in the Medical Management of Type 2 Diabetes: Reflections on Recent Cardiovascular Outcome Trials. Journal of General Internal Medicine. PMID 28550608 DOI: 10.1007/S11606-017-4061-7 |
0.358 |
|
| 2017 |
Hashemi Madani N, Ismail-Beigi F, Khamseh ME, Malek M, Ebrahimi Valojerdi A. Predictive and explanatory factors of cardiovascular disease in people with adequately controlled type 2 diabetes. European Journal of Preventive Cardiology. 2047487317707293. PMID 28447480 DOI: 10.1177/2047487317707293 |
0.338 |
|
| 2017 |
Inzucchi SE, Viscoli CM, Young LH, Furie KL, Gorman M, Lovejoy AM, Dagogo-Jack S, Ismail-Beigi F, Korytkowski MT, Pratley RE, Schwartz GG, Kernan WN. Response to Comment on Inzucchi et al. Pioglitazone Prevents Diabetes in Patients With Insulin Resistance and Cerebrovascular Disease. Diabetes Care 2016;39:1684-1692. Diabetes Care. 40: e47-e48. PMID 28325804 DOI: 10.2337/Dci16-0048 |
0.346 |
|
| 2016 |
Elam MB, Ginsberg HN, Lovato LC, Corson M, Largay J, Leiter LA, Lopez C, O'Connor PJ, Sweeney ME, Weiss D, Friedewald WT, Buse JB, Gerstein HC, Probstfield J, Grimm R, ... Ismail-Beigi F, et al. Association of Fenofibrate Therapy With Long-term Cardiovascular Risk in Statin-Treated Patients With Type 2 Diabetes. Jama Cardiology. PMID 28030716 DOI: 10.1001/Jamacardio.2016.4828 |
0.318 |
|
| 2016 |
Inzucchi SE, Viscoli CM, Young LH, Furie KL, Gorman M, Lovejoy AM, Dagogo-Jack S, Ismail-Beigi F, Korytkowski MT, Pratley RE, Schwartz GG, Kernan WN. Pioglitazone Prevents Diabetes in Insulin-Resistant Patients With Cerebrovascular Disease. Diabetes Care. PMID 27465265 DOI: 10.2337/Dc16-0798 |
0.316 |
|
| 2016 |
Nadkarni GN, Rao V, Ismail-Beigi F, Fonseca VA, Shah SV, Simonson MS, Cantley L, Devarajan P, Parikh CR, Coca SG. Association of Urinary Biomarkers of Inflammation, Injury, and Fibrosis with Renal Function Decline: The ACCORD Trial. Clinical Journal of the American Society of Nephrology : Cjasn. PMID 27189318 DOI: 10.2215/Cjn.12051115 |
0.56 |
|
| 2016 |
Chew EY, Lovato JF, Davis MD, Gerstein HC, Danis RP, Ismail-Beigi F, Genuth S, Greven CM, Perdue LH, Cushman WC, Elam MB, Thomas Bigger J, Ginsberg HN, Goff DC, Ambrosius WT. Persistent effects of intensive glycemic control on retinopathy in type 2 diabetes in the action to control cardiovascular risk in diabetes (ACCORD) follow-on study Diabetes Care. 39: 1089-1100. DOI: 10.2337/Dc16-0024 |
0.354 |
|
| 2016 |
Gerstein HC, Beavers DP, Bertoni AG, Bigger JT, Buse JB, Craven TE, Cushman WC, Fonseca V, Geller NL, Giddings SJ, Grimm RH, Genuth S, Hramiak I, Ismail-Beigi F, Jimenez CRL, et al. Nine-year effects of 3.7 years of intensive glycemic control on cardiovascular outcomes Diabetes Care. 39: 701-708. DOI: 10.2337/Dc15-2283 |
0.322 |
|
| 2015 |
Siraj ES, Rubin DJ, Riddle MC, Miller ME, Hsu FC, Ismail-Beigi F, Chen SH, Ambrosius WT, Thomas A, Bestermann W, Buse JB, Genuth S, Joyce C, Kovacs CS, O'Connor PJ, et al. Insulin Dose and Cardiovascular Mortality in the ACCORD Trial. Diabetes Care. PMID 26464212 DOI: 10.2337/Dc15-0598 |
0.56 |
|
| 2015 |
Zonszein J, Lombardero M, Ismail-Beigi F, Palumbo P, Foucher S, Groenewoud Y, Cushing G, Wajchenberg B, Genuth S. Triglyceride High-Density Lipoprotein Ratios Predict Glycemia-Lowering in Response to Insulin Sensitizing Drugs in Type 2 Diabetes: A Post Hoc Analysis of the BARI 2D. Journal of Diabetes Research. 2015: 129891. PMID 26106623 DOI: 10.1155/2015/129891 |
0.363 |
|
| 2014 |
Pandyarajan V, Smith BJ, Phillips NB, Whittaker L, Cox GP, Wickramasinghe N, Menting JG, Wan ZL, Whittaker J, Ismail-Beigi F, Lawrence MC, Weiss MA. Aromatic anchor at an invariant hormone-receptor interface: function of insulin residue B24 with application to protein design. The Journal of Biological Chemistry. 289: 34709-27. PMID 25305014 DOI: 10.1074/Jbc.M114.608562 |
0.306 |
|
| 2014 |
Zhang Z, Lovato J, Battapady H, Davatzikos C, Gerstein HC, Ismail-Beigi F, Launer LJ, Murray A, Punthakee Z, Tirado AA, Williamson J, Bryan RN, Miller ME. Effect of hypoglycemia on brain structure in people with type 2 diabetes: epidemiological analysis of the ACCORD-MIND MRI trial. Diabetes Care. 37: 3279-85. PMID 25267796 DOI: 10.2337/Dc14-0973 |
0.314 |
|
| 2014 |
Chew EY, Davis MD, Danis RP, Lovato JF, Perdue LH, Greven C, Genuth S, Goff DC, Leiter LA, Ismail-Beigi F, Ambrosius WT. The effects of medical management on the progression of diabetic retinopathy in persons with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Eye Study. Ophthalmology. 121: 2443-51. PMID 25172198 DOI: 10.1016/J.Ophtha.2014.07.019 |
0.354 |
|
| 2014 |
Bansal V, Davis GM, Ismail-Beigi F. Risk of insulin accumulation (stacking) with use of novel ultralong-acting insulin formulations. Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 20: 990-1. PMID 25100381 DOI: 10.4158/Ep14144.Co |
0.315 |
|
| 2014 |
Gerstein HC, Miller ME, Ismail-Beigi F, Largay J, McDonald C, Lochnan HA, Booth GL. Effects of intensive glycaemic control on ischaemic heart disease: analysis of data from the randomised, controlled ACCORD trial. Lancet. 384: 1936-41. PMID 25088437 DOI: 10.1016/S0140-6736(14)60611-5 |
0.348 |
|
| 2014 |
Pandyarajan V, Phillips NB, Cox GP, Yang Y, Whittaker J, Ismail-Beigi F, Weiss MA. Biophysical optimization of a therapeutic protein by nonstandard mutagenesis: studies of an iodo-insulin derivative. The Journal of Biological Chemistry. 289: 23367-81. PMID 24993826 DOI: 10.1074/Jbc.M114.588277 |
0.356 |
|
| 2014 |
Punthakee Z, Miller ME, Simmons DL, Riddle MC, Ismail-Beigi F, Brillon DJ, Bergenstal RM, Savage PJ, Hramiak I, Largay JF, Sood A, Gerstein HC. Durable change in glycaemic control following intensive management of type 2 diabetes in the ACCORD clinical trial. Diabetologia. 57: 2030-7. PMID 24985147 DOI: 10.1007/S00125-014-3318-5 |
0.326 |
|
| 2014 |
Su KH, Chandramouli V, Ismail-Beigi F, Muzic RF. Dexamethasone-induced insulin resistance: kinetic modeling using novel PET radiopharmaceutical 6-deoxy-6-[(18)F]fluoro-D-glucose. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 16: 710-20. PMID 24819311 DOI: 10.1007/S11307-014-0737-0 |
0.322 |
|
| 2014 |
Linz PE, Lovato LC, Byington RP, O'Connor PJ, Leiter LA, Weiss D, Force RW, Crouse JR, Ismail-Beigi F, Simmons DL, Papademetriou V, Ginsberg HN, Elam MB. Paradoxical reduction in HDL-C with fenofibrate and thiazolidinedione therapy in type 2 diabetes: the ACCORD Lipid Trial. Diabetes Care. 37: 686-93. PMID 24296848 DOI: 10.2337/Dc13-0790 |
0.309 |
|
| 2014 |
Ismail-Beigi F, Lombardero MS, Escobedo J, Genuth S, Green J, Massaro E, Mooradian AD, Ovalle F, Whitehouse F, Zonszein J. Determinants of successful glycemic control among participants in the BARI 2D trial: a post-hoc analysis. Journal of Diabetes and Its Complications. 28: 101-9. PMID 23478173 DOI: 10.1016/J.Jdiacomp.2013.01.006 |
0.32 |
|
| 2013 |
Moghissi E, Ismail-Beigi F, Devine RC. Hypoglycemia: minimizing its impact in type 2 diabetes. Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 19: 526-35. PMID 23425655 DOI: 10.4158/Ep13005.Ra |
0.347 |
|
| 2013 |
Fonseca V, McDuffie R, Calles J, Cohen RM, Feeney P, Feinglos M, Gerstein HC, Ismail-Beigi F, Morgan TM, Pop-Busui R, Riddle MC. Determinants of weight gain in the action to control cardiovascular risk in diabetes trial. Diabetes Care. 36: 2162-8. PMID 23412077 DOI: 10.2337/Dc12-1391 |
0.341 |
|
| 2013 |
Gerstein HC, Ambrosius WT, Danis R, Ismail-Beigi F, Cushman W, Calles J, Banerji M, Schubart U, Chew EY. Diabetic retinopathy, its progression, and incident cardiovascular events in the ACCORD trial. Diabetes Care. 36: 1266-71. PMID 23238658 DOI: 10.2337/Dc12-1311 |
0.342 |
|
| 2013 |
Faghihimani E, Aminorroaya A, Rezvanian H, Adibi P, Ismail-Beigi F, Amini M. Salsalate improves glycemic control in patients with newly diagnosed type 2 diabetes. Acta Diabetologica. 50: 537-43. PMID 21938543 DOI: 10.1007/S00592-011-0329-2 |
0.337 |
|
| 2012 |
Huang HM, Chandramouli V, Ismail-Beigi F, Muzic RF. Hyperglycemia-induced stimulation of glucose transport in skeletal muscle measured by PET-[18F]6FDG and [18F]2FDG. Physiological Measurement. 33: 1661-73. PMID 22986442 DOI: 10.1088/0967-3334/33/10/1661 |
0.304 |
|
| 2012 |
Faghihimani E, Aminorroaya A, Rezvanian H, Adibi P, Ismail-Beigi F, Amini M. Reduction of insulin resistance and plasma glucose level by salsalate treatment in persons with prediabetes. Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 18: 826-33. PMID 22784842 DOI: 10.4158/Ep12064.Or |
0.332 |
|
| 2012 |
Taheri N, Aminorroaya A, Ismail-Beigi F, Amini M. Effect of dexamethasone on glucose homeostasis in normal and prediabetic subjects with a first-degree relative with type 2 diabetes mellitus. Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 18: 855-63. PMID 22784841 DOI: 10.4158/Ep12057.Or |
0.375 |
|
| 2012 |
Bonds DE, Miller ME, Dudl J, Feinglos M, Ismail-Beigi F, Malozowski S, Seaquist E, Simmons DL, Sood A. Severe hypoglycemia symptoms, antecedent behaviors, immediate consequences and association with glycemia medication usage: Secondary analysis of the ACCORD clinical trial data. Bmc Endocrine Disorders. 12: 5. PMID 22646230 DOI: 10.1186/1472-6823-12-5 |
0.317 |
|
| 2012 |
Coca SG, Ismail-Beigi F, Haq N, Krumholz HM, Parikh CR. Role of intensive glucose control in development of renal end points in type 2 diabetes mellitus: systematic review and meta-analysis intensive glucose control in type 2 diabetes. Archives of Internal Medicine. 172: 761-9. PMID 22636820 DOI: 10.1001/Archinternmed.2011.2230 |
0.396 |
|
| 2012 |
Simonson MS, Tiktin M, Debanne SM, Rahman M, Berger B, Hricik D, Ismail-Beigi F. The renal transcriptome of db/db mice identifies putative urinary biomarker proteins in patients with type 2 diabetes: a pilot study. American Journal of Physiology. Renal Physiology. 302: F820-9. PMID 22205226 DOI: 10.1152/Ajprenal.00424.2011 |
0.598 |
|
| 2012 |
Genuth S, Ismail-Beigi F. Clinical implications of the ACCORD trial Journal of Clinical Endocrinology and Metabolism. 97: 41-48. PMID 22049171 DOI: 10.1210/Jc.2011-1679 |
0.305 |
|
| 2011 |
O'Connor PJ, Ismail-Beigi F. Near-Normalization of Glucose and Microvascular Diabetes Complications: Data from ACCORD and ADVANCE. Therapeutic Advances in Endocrinology and Metabolism. 2: 17-26. PMID 23148169 DOI: 10.1177/2042018810390545 |
0.406 |
|
| 2011 |
Ismail-Beigi F, Moghissi E, Tiktin M, Hirsch IB, Inzucchi SE, Genuth S. Individualizing glycemic targets in type 2 diabetes mellitus: implications of recent clinical trials. Annals of Internal Medicine. 154: 554-9. PMID 21502652 DOI: 10.7326/0003-4819-154-8-201104190-00007 |
0.343 |
|
| 2011 |
Gerstein HC, Miller ME, Genuth S, Ismail-Beigi F, Buse JB, Goff DC, Probstfield JL, Cushman WC, Ginsberg HN, Bigger JT, Grimm RH, Byington RP, Rosenberg YD, Friedewald WT. Long-term effects of intensive glucose lowering on cardiovascular outcomes. The New England Journal of Medicine. 364: 818-28. PMID 21366473 DOI: 10.1056/Nejmoa1006524 |
0.367 |
|
| 2011 |
Simonson MS, Ismail-Beigi F. Endothelin-1 increases collagen accumulation in renal mesangial cells by stimulating a chemokine and cytokine autocrine signaling loop. The Journal of Biological Chemistry. 286: 11003-8. PMID 21169360 DOI: 10.1074/Jbc.M110.190793 |
0.557 |
|
| 2011 |
Ismail-Beigi F. Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial--clinical implications. Clinical Chemistry. 57: 261-3. PMID 20974799 DOI: 10.1373/Clinchem.2010.148288 |
0.362 |
|
| 2011 |
Wolfram T, Ismail-Beigi F. Efficacy of high-fiber diets in the management of type 2 diabetes mellitus. Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 17: 132-42. PMID 20713332 DOI: 10.4158/Ep10204.Ra |
0.313 |
|
| 2011 |
O’Connor P, Ismail-Beigi F. PS2-27: Near-Normalization of Glucose and Microvascular Diabetes Complications: Data from ACCORD and ADVANCE Clinical Medicine & Research. 9: 159-160. DOI: 10.3121/Cmr.2011.1020.Ps2-27 |
0.406 |
|
| 2010 |
Nyalakonda K, Sharma T, Ismail-Beigi F. Preservation of beta-cell function in type 2 diabetes. Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 16: 1038-55. PMID 21030360 DOI: 10.4158/Ep10112.Ra |
0.319 |
|
| 2010 |
Ismail-Beigi F, Craven T, Banerji MA, Basile J, Calles J, Cohen RM, Cuddihy R, Cushman WC, Genuth S, Grimm RH, Hamilton BP, Hoogwerf B, Karl D, Katz L, Krikorian A, et al. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet. 376: 419-30. PMID 20594588 DOI: 10.1016/S0140-6736(10)60576-4 |
0.333 |
|
| 2010 |
Sood A, Ismail-Beigi F. Effect of dexamethasone on insulin secretion: examination of underlying mechanisms. Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 16: 763-9. PMID 20350918 DOI: 10.4158/Ep09372.Or |
0.326 |
|
| 2010 |
Abdelmannan D, Tahboub R, Genuth S, Ismail-Beigi F. Effect of dexamethasone on oral glucose tolerance in healthy adults. Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 16: 770-7. PMID 20350917 DOI: 10.4158/Ep09373.Or |
0.315 |
|
| 2010 |
Ginsberg HN, Elam MB, Lovato LC, Crouse JR, Leiter LA, Linz P, Friedewald WT, Buse JB, Gerstein HC, Probstfield J, Grimm RH, Ismail-Beigi F, Bigger JT, Goff DC, et al. Effects of combination lipid therapy in type 2 diabetes mellitus. The New England Journal of Medicine. 362: 1563-74. PMID 20228404 DOI: 10.1056/Nejmoa1001282 |
0.329 |
|
| 2010 |
Phillips NB, Wan ZL, Whittaker L, Hu SQ, Huang K, Hua QX, Whittaker J, Ismail-Beigi F, Weiss MA. Supramolecular protein engineering: design of zinc-stapled insulin hexamers as a long acting depot. The Journal of Biological Chemistry. 285: 11755-9. PMID 20181952 DOI: 10.1074/Jbc.C110.105825 |
0.327 |
|
| 2010 |
Calles-Escandón J, Lovato LC, Simons-Morton DG, Kendall DM, Pop-Busui R, Cohen RM, Bonds DE, Fonseca VA, Ismail-Beigi F, Banerji MA, Failor A, Hamilton B. Effect of intensive compared with standard glycemia treatment strategies on mortality by baseline subgroup characteristics: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Diabetes Care. 33: 721-7. PMID 20103550 DOI: 10.2337/Dc09-1471 |
0.332 |
|
| 2010 |
Bonds DE, Miller ME, Bergenstal RM, Buse JB, Byington RP, Cutler JA, Dudl RJ, Ismail-Beigi F, Kimel AR, Hoogwerf B, Horowitz KR, Savage PJ, Seaquist ER, Simmons DL, Sivitz WI, et al. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study. Bmj (Clinical Research Ed.). 340: b4909. PMID 20061358 DOI: 10.1136/Bmj.B4909 |
0.345 |
|
| 2010 |
Krikorian A, Ismail-Beigi F, Moghissi ES. Comparisons of different insulin infusion protocols: a review of recent literature. Current Opinion in Clinical Nutrition and Metabolic Care. 13: 198-204. PMID 20040862 DOI: 10.1097/Mco.0B013E32833571Db |
0.308 |
|
| 2010 |
Ismail-Beigi F, Craven T, Banerji MA. Erratum: Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: An analysis of the ACCORD randomised trial (The Lancet (2010) 376 (419-430)) The Lancet. 376. DOI: 10.1016/S0140-6736(10)61995-2 |
0.328 |
|
| 2009 |
Zhao M, Wan ZL, Whittaker L, Xu B, Phillips NB, Katsoyannis PG, Ismail-Beigi F, Whittaker J, Weiss MA. Design of an insulin analog with enhanced receptor binding selectivity: rationale, structure, and therapeutic implications. The Journal of Biological Chemistry. 284: 32178-87. PMID 19773552 DOI: 10.1074/Jbc.M109.028399 |
0.322 |
|
| 2009 |
Moghissi ES, Korytkowski MT, DiNardo M, Einhorn D, Hellman R, Hirsch IB, Inzucchi SE, Ismail-Beigi F, Kirkman MS, Umpierrez GE. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 15: 353-69. PMID 19454396 DOI: 10.4158/Ep09102.Ra |
0.31 |
|
| 2009 |
Spring-Robinson C, Chandramouli V, Schumann WC, Faulhaber PF, Wang Y, Wu C, Ismail-Beigi F, Muzic RF. Uptake of 18F-labeled 6-fluoro-6-deoxy-D-glucose by skeletal muscle is responsive to insulin stimulation. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 50: 912-9. PMID 19443592 DOI: 10.2967/Jnumed.109.062687 |
0.346 |
|
| 2009 |
Moghissi ES, Korytkowski MT, DiNardo M, Einhorn D, Hellman R, Hirsch IB, Inzucchi SE, Ismail-Beigi F, Kirkman MS, Umpierrez GE. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care. 32: 1119-31. PMID 19429873 DOI: 10.2337/Dc09-9029 |
0.34 |
|
| 2008 |
Kemp DE, Calabrese JR, Ismail-Beigi F. Depressive symptoms and diabetes. Jama. 300: 2115-6; author reply. PMID 19001617 DOI: 10.1001/Jama.2008.565 |
0.317 |
|
| 2008 |
Ismail-Beigi F, Moghissi ES. Glycemia management and cardiovascular risk in type 2 diabetes: an evolving perspective. Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 14: 639-43. PMID 18753110 DOI: 10.4158/Ep.14.5.639 |
0.346 |
|
| 2008 |
Jing M, Cheruvu VK, Ismail-Beigi F. Stimulation of glucose transport in response to activation of distinct AMPK signaling pathways. American Journal of Physiology. Cell Physiology. 295: C1071-82. PMID 18701654 DOI: 10.1152/Ajpcell.00040.2008 |
0.353 |
|
| 2008 |
Gerstein HC, Miller ME, Byington RP, Goff DC, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH, Probstfield JL, Simons-Morton DG, Friedewald WT. Effects of intensive glucose lowering in type 2 diabetes. The New England Journal of Medicine. 358: 2545-59. PMID 18539917 DOI: 10.1056/Nejmoa0802743 |
0.377 |
|
| 2007 |
Gerstein HC, Riddle MC, Kendall DM, Cohen RM, Goland R, Feinglos MN, Kirk JK, Hamilton BP, Ismail-Beigi F, Feeney P. Glycemia treatment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. The American Journal of Cardiology. 99: 34i-43i. PMID 17599423 DOI: 10.1016/J.Amjcard.2007.03.004 |
0.413 |
|
| 2007 |
Landau BR, Spring-Robinson CL, Muzic RF, Rachdaoui N, Rubin D, Berridge MS, Schumann WC, Chandramouli V, Kern TS, Ismail-Beigi F. 6-Fluoro-6-deoxy-D-glucose as a tracer of glucose transport. American Journal of Physiology. Endocrinology and Metabolism. 293: E237-45. PMID 17405828 DOI: 10.1152/Ajpendo.00022.2007 |
0.549 |
|
| 2007 |
Jing M, Ismail-Beigi F. Critical role of 5'-AMP-activated protein kinase in the stimulation of glucose transport in response to inhibition of oxidative phosphorylation. American Journal of Physiology. Cell Physiology. 292: C477-87. PMID 16943243 DOI: 10.1152/Ajpcell.00196.2006 |
0.358 |
|
| 2006 |
El-Kebbi IM, Ibrahim MA, Ismail-Beigi F. Recommendations for management of diabetes during Ramadan: Response to Elhadd and Al-Amoudi and to Davidson [8] Diabetes Care. 29: 746. DOI: 10.2337/Diacare.29.03.06.Dc05-2302 |
0.338 |
|
| 2005 |
Al-Arouj M, Bouguerra R, Buse J, Hafez S, Hassanein M, Ibrahim MA, Ismail-Beigi F, El-Kebbi I, Khatib O, Kishawi S, Al-Madani A, Mishal AA, Al-Maskari M, Nakhi AB, Al-Rubean K. Recommendations for management of diabetes during Ramadan. Diabetes Care. 28: 2305-11. PMID 16123509 DOI: 10.2337/Diacare.28.9.2305 |
0.346 |
|
| 2004 |
Rubin D, Ismail-Beigi F. Differential accumulation of Glut1 in the non-DRM domain of the plasma membrane in response to the inhibition of oxidative phosphorylation. Archives of Biochemistry and Biophysics. 431: 224-32. PMID 15488471 DOI: 10.1016/J.Abb.2004.08.007 |
0.533 |
|
| 2003 |
Rubin D, Ismail-Beigi F. Distribution of Glut1 in detergent-resistant membranes (DRMs) and non-DRM domains: effect of treatment with azide. American Journal of Physiology. Cell Physiology. 285: C377-83. PMID 12686514 DOI: 10.1152/Ajpcell.00060.2003 |
0.533 |
|
| 2002 |
Hwang DY, Ismail-Beigi F. Glucose uptake and lactate production in cells exposed to CoCl(2) and in cells overexpressing the Glut-1 glucose transporter. Archives of Biochemistry and Biophysics. 399: 206-11. PMID 11888207 DOI: 10.1006/Abbi.2002.2758 |
0.377 |
|
| 2001 |
Hwang DY, Ismail-Beigi F. Stimulation of GLUT-1 glucose transporter expression in response to hyperosmolarity American Journal of Physiology - Cell Physiology. 281. PMID 11546675 DOI: 10.1152/Ajpcell.2001.281.4.C1365 |
0.39 |
|
| 2001 |
Zhang JZ, Abbud W, Prohaska R, Ismail-Beigi F. Overexpression of stomatin depresses GLUT-1 glucose transporter activity American Journal of Physiology - Cell Physiology. 280. PMID 11287341 DOI: 10.1152/Ajpcell.2001.280.5.C1277 |
0.37 |
|
| 2000 |
Abbud W, Habinowski S, Zhang JZ, Kendrew J, Elkairi FS, Kemp BE, Witters LA, Ismail-Beigi F. Stimulation of AMP-activated protein kinase (AMPK) is associated with enhancement of Glut1-mediated glucose transport Archives of Biochemistry and Biophysics. 380: 347-352. PMID 10933890 DOI: 10.1006/Abbi.2000.1935 |
0.375 |
|
| 2000 |
Badr GA, Tang J, Ismail-Beigi F, Kern TS. Diabetes downregulates GLUT1 expression in the retina and its microvessels but not in the cerebral cortex or its microvessels Diabetes. 49: 1016-1021. PMID 10866055 DOI: 10.2337/Diabetes.49.6.1016 |
0.372 |
|
| 1999 |
Behrooz A, Ismail-Beigi F. Stimulation of Glucose Transport by Hypoxia: Signals and Mechanisms. News in Physiological Sciences : An International Journal of Physiology Produced Jointly by the International Union of Physiological Sciences and the American Physiological Society. 14: 105-110. PMID 11390832 DOI: 10.1152/Physiologyonline.1999.14.3.105 |
0.345 |
|
| 1999 |
Zhang JZ, Hayashi H, Ebina Y, Prohaska R, Ismail-Beigi F. Association of stomatin (band 7.2b) with Glut1 glucose transporter Archives of Biochemistry and Biophysics. 372: 173-178. PMID 10562431 DOI: 10.1006/Abbi.1999.1489 |
0.333 |
|
| 1999 |
Hamrahian AH, Zhang JZ, Elkhairi FS, Prasad R, Ismail-Beigi F. Activation of Glut1 glucose transporter in response to inhibition of oxidative phosphorylation. Role of sites of mitochondrial inhibition and mechanism of Glut1 activation Archives of Biochemistry and Biophysics. 368: 375-379. PMID 10441390 DOI: 10.1006/Abbi.1999.1320 |
0.374 |
|
| 1999 |
Zhang JZ, Behrooz A, Ismail-Beigi F. Regulation of glucose transport by hypoxia American Journal of Kidney Diseases. 34: 189-202. PMID 10401038 DOI: 10.1016/S0272-6386(99)70131-9 |
0.37 |
|
| 1999 |
Saker F, Voora DM, Mahajan SD, Kiliç I, Ismail-Beigi F, Kalhan SC. Effect of reduced inspired oxygen on fetal growth and maternal glucose metabolism in rat pregnancy Metabolism: Clinical and Experimental. 48: 738-744. PMID 10381148 DOI: 10.1016/S0026-0495(99)90173-7 |
0.331 |
|
| 1999 |
Prasad RK, Behrooz A, Ismail-Beigi F. LY-83583 stimulates glucose transporter-1-mediated glucose transport independent of changes in cGMP levels European Journal of Pharmacology. 366: 101-109. PMID 10064158 DOI: 10.1016/S0014-2999(98)00893-0 |
0.386 |
|
| 1999 |
Yalcin Y, Carman D, Shao Y, Ismail-Beigi F, Klein I, Ojamaa K. Regulation of Na/K-ATPase gene expression by thyroid hormone and hyperkalemia in the heart Thyroid. 9: 53-59. PMID 10037077 DOI: 10.1089/Thy.1999.9.53 |
0.306 |
|
| 1999 |
Prasad RK, Ismail-Beigi F. Mechanism of stimulation of glucose transport by H2O2: Role of phospholipase C Archives of Biochemistry and Biophysics. 362: 113-122. PMID 9917335 DOI: 10.1006/Abbi.1998.1026 |
0.375 |
|
| 1999 |
Badr GA, Zhang JZ, Tang J, Kern TS, Ismail-Beigi F. Glut1 and glut3 expression, but not capillary density, is increased by cobalt chloride in rat cerebrum and retina Molecular Brain Research. 64: 24-33. PMID 9889305 DOI: 10.1016/S0169-328X(98)00301-5 |
0.314 |
|
| 1998 |
Behrooz A, Ismail-Beigi F. Induction of GLUT1 mRNA in response to azide and inhibition of protein synthesis Molecular and Cellular Biochemistry. 187: 33-40. PMID 9788740 DOI: 10.1023/A:1006894527145 |
0.325 |
|
| 1998 |
Zhang JZ, Ismail-Beigi F. Activation of glut1 glucose transporter in human erythrocytes Archives of Biochemistry and Biophysics. 356: 86-92. PMID 9681995 DOI: 10.1006/Abbi.1998.0760 |
0.37 |
|
| 1998 |
Saker F, Ybarra J, Leahy P, Hanson RW, Kalhan SC, Ismail-Beigi F. Glycemia-lowering effect of cobalt chloride in the diabetic rat: role of decreased gluconeogenesis. The American Journal of Physiology. 274: E984-91. PMID 9611146 DOI: 10.1152/Ajpendo.1998.274.6.E984 |
0.412 |
|
| 1997 |
Ybarra J, Behrooz A, Gabriel A, Koseoglu MH, Ismail-Beigi F. Glycemia-lowering effect of cobalt chloride in the diabetic rat: Increased GLUT1 mRNA expression Molecular and Cellular Endocrinology. 133: 151-160. PMID 9406861 DOI: 10.1016/S0303-7207(97)00162-7 |
0.386 |
|
| 1997 |
Esterman A, Greco MA, Mitani Y, Finlay TH, Ismail-Beigi F, Dancis J. The effect of hypoxia on human trophoblast in culture: Morphology, glucose transport and metabolism Placenta. 18: 129-136. PMID 9089773 DOI: 10.1016/S0143-4004(97)90084-9 |
0.31 |
|
| 1997 |
Behrooz A, Ismail-Beigi F. Dual control of glut1 glucose transporter gene expression by hypoxia and by inhibition of oxidative phosphorylation Journal of Biological Chemistry. 272: 5555-5562. PMID 9038162 DOI: 10.1074/Jbc.272.9.5555 |
0.366 |
|
| 1997 |
Saker F, Voora D, Mahajan S, Ismail-Beigi F, Kalhan S. Maternal Hypoxemia in Rat Induces Fetal Growth Retardation But Does Not Effect Tissue Glucose Uptake or Placental Glucose Transporters. † 1424 Pediatric Research. 41: 240-240. DOI: 10.1203/00006450-199704001-01443 |
0.326 |
|
| 1996 |
Shetty M, Kuruvilla AK, Ismail-Beigi F, Loeb JN. Stimulation of glucose transport in Clone 9 cells by insulin and thyroid hormone: role of GLUT-1 activation. Biochimica Et Biophysica Acta. 1314: 140-6. PMID 8972727 DOI: 10.1016/S0167-4889(96)00069-9 |
0.395 |
|
| 1996 |
Becker M, Newman S, Ismail-Beigi F. Stimulation of GLUT1 glucose transporter expression in response to inhibition of oxidative phosphorylation: Role of reduced sulfhydryl groups Molecular and Cellular Endocrinology. 121: 165-170. PMID 8892317 DOI: 10.1016/0303-7207(96)03862-2 |
0.337 |
|
| 1996 |
Ismail-Beigi F, Vanderburg G. Effect of GLUT1 glucose transporter overexpression on the stimulation of glucose transport in response to inhibition of oxidative phosphorylation Archives of Biochemistry and Biophysics. 331: 201-207. PMID 8660699 DOI: 10.1006/Abbi.1996.0299 |
0.388 |
|
| 1996 |
Esterman A, Finlay TH, Greco MA, Mitani Y, Ismail-Beigi F, Dancis J. Response Of Human Trophoblast To Hypoxia: Morphology, Glucose Transport And Metabolism, Endocrine Synthesis. † 1230 Pediatric Research. 39: 207-207. DOI: 10.1203/00006450-199604001-01252 |
0.328 |
|
| 1995 |
Shi Y, Liu H, Vanderburg G, Samuel SJ, Ismail-Beigi F, Jung CY. Modulation of GLUT1 intrinsic activity in clone 9 cells by inhibition of oxidative phosphorylation Journal of Biological Chemistry. 270: 21772-21778. PMID 7665597 DOI: 10.1074/Jbc.270.37.21772 |
0.341 |
|
| 1995 |
Mitani Y, Behrooz A, Dubyak GR, Ismail-Beigi F. Stimulation of GLUT-1 glucose transporter expression in response to exposure to calcium ionophore A-23187 American Journal of Physiology - Cell Physiology. 269. PMID 7491913 DOI: 10.1152/Ajpcell.1995.269.5.C1228 |
0.363 |
|
| 1994 |
Kirtane A, Ismail-Beigi N, Ismail-Beigi F. Role of enhanced Na+ entry in the control of Na,K-ATPase gene expression by serum The Journal of Membrane Biology. 137: 9-15. PMID 8006948 DOI: 10.1007/Bf00234994 |
0.304 |
|
| 1993 |
Ismail-Beigi F. Metabolic regulation of glucose transport The Journal of Membrane Biology. 135: 1-10. PMID 8411128 DOI: 10.1007/Bf00234646 |
0.367 |
|
| 1993 |
Shetty M, Ismail-Beigi N, Loeb JN, Ismail-Beigi F. Induction of GLUT1 mRNA in response to inhibition of oxidative phosphorylation. The American Journal of Physiology. 265: C1224-9. PMID 7694490 DOI: 10.1152/Ajpcell.1993.265.5.C1224 |
0.332 |
|
| 1993 |
Ismail-Beigi F. Thyroid hormone regulation of Na,K-ATPase expression Trends in Endocrinology and Metabolism. 4: 152-155. DOI: 10.1016/1043-2760(93)90104-M |
0.304 |
|
| 1992 |
Shetty M, Loeb JN, Ismail-Beigi F. Enhancement of glucose transport in response to inhibition of oxidative metabolism: pre- and posttranslational mechanisms. The American Journal of Physiology. 262: C527-32. PMID 1539639 DOI: 10.1152/Ajpcell.1992.262.2.C527 |
0.386 |
|
| 1991 |
Perez C, Bhutada A, Ismail-Beigi F. Induction of Na+-K+-ATPase subunit mRNAs by cycloheximide in a rat liver cell line American Journal of Physiology - Cell Physiology. 260. PMID 1848399 DOI: 10.1152/Ajpcell.1991.260.3.C417 |
0.314 |
|
| 1991 |
Kuruvilla AK, Perez C, Ismail-Beigi F, Loeb JN. Regulation of glucose transport in Clone 9 cells by thyroid hormone. Biochimica Et Biophysica Acta. 1094: 300-8. PMID 1716988 DOI: 10.1016/0167-4889(91)90090-K |
0.376 |
|
| 1991 |
Hakimian J, Ismail-Beigi F. Enhancement of Glucose transport in clone 9 cells by exposure to alkaline pH: Studies on potential mechanisms The Journal of Membrane Biology. 120: 29-39. PMID 1708427 DOI: 10.1007/Bf01868588 |
0.349 |
|
| 1991 |
Bhutada A, Ismail-Beigi F. Serum and growth factor induction of Na+-K+-ATPase subunit mRNAs in Clone 9 cells: Role of protein kinase C American Journal of Physiology - Cell Physiology. 261. PMID 1656770 DOI: 10.1152/Ajpcell.1991.261.4.C699 |
0.31 |
|
| 1990 |
Ismail-Beigi F, Mercado CL, Loeb JN. Stimulation of glucose transport in Clone 9 cells by exposure to alkaline pH. The American Journal of Physiology. 258: C327-35. PMID 2305872 DOI: 10.1152/Ajpcell.1990.258.2.C327 |
0.342 |
|
| 1990 |
Gick GG, Melikian J, Ismail-Beigi F. Thyroidal enhancement of rat myocardial Na,K-ATPase: Preferential expression of α2 activity and mRNA abundance The Journal of Membrane Biology. 115: 273-282. PMID 2165172 DOI: 10.1007/Bf01868642 |
0.304 |
|
| 1990 |
Bhutada A, Perez C, Chon DY, Ismail-Beigi F. Induction of Na+-K+-ATPase and its subunit mRNAs by serum in a rat liver cell line American Journal of Physiology - Cell Physiology. 258. PMID 2163196 DOI: 10.1152/Ajpcell.1990.258.6.C1044 |
0.302 |
|
| 1990 |
Gick GG, Ismail-Beigi F. Thyroid hormone induction of Na+-K+-ATPase and its mRNAs in a rat liver cell line American Journal of Physiology - Cell Physiology. 258. PMID 2156438 DOI: 10.1152/Ajpcell.1990.258.3.C544 |
0.301 |
|
| 1989 |
Mercado CL, Loeb JN, Ismail-Beigi F. Enhanced glucose transport in response to inhibition of respiration in Clone 9 cells. The American Journal of Physiology. 257: C19-28. PMID 2750888 DOI: 10.1152/Ajpcell.1989.257.1.C19 |
0.376 |
|
| Show low-probability matches. |